A test for SARS-CoV-2 viruses in humans is shown in field tests to return diagnostic results in 90 minutes with accuracy comparable to the gold-standard RT-PCR test. . . . → Read More: Point-of-Care Covid-19 Diagnostic Shows High Accuracy
|
|||||
       |
 One comment - (Comments are closed)  New products  biomedical, Covid-19, engineering, entrepreneurs, life sciences, medical device, software, U.K., university 
Evidence collected from electronic neuro-stimulation devices shows for most people the wearable systems relieve migraine pain without other drugs. . . . → Read More: Wearable Device Shown to Relieve Migraine Pain 2 comments - (Comments are closed) New products biomedical, engineering, Israel, life sciences, medical device, software, university 
Two biotechnology companies are adding to their current collaboration to develop delivery techniques for gene-editing treatments for cystic fibrosis. . . . → Read More: Biotechs Partner on Gene-Editing Cystic Fibrosis Therapy Comments are closed Joint ventures/collaborations biomedical, biotechnology, genomics, life sciences, pharmaceuticals 
First results from a clinical trial testing an experimental synthetic antibody, show patients receiving the therapy at a specific dosage, cleared their SARS-CoV-2 viruses within 11 days. . . . → Read More: Early Trial Results Show Antibody Treating Covid-19 2 comments - (Comments are closed) New products biomedical, biotechnology, Canada, clinical trials, Covid-19, life sciences, pharmaceuticals 
The nation and the world aren’t the ones facing health issues., even intrepid business/science writers and editors. . . . → Read More: No Posts Today 
A company creating cancer therapies with individualized engineered T-cells is raising $110 million in its first venture funding round. . . . → Read More: Precision Cancer Therapy Start-Up Gains $110M in Early Funds One comment - (Comments are closed) Finance, New products biomedical, biotechnology, cancer, entrepreneurs, equity, genomics, investment, life sciences, pharmaceuticals, preclinical, venture capital 
Gilead Sciences is acquiring biotechnology company Immunomedics, specializing in immunotherapies for cancer and other diseases, in a deal valued at $21 billion. . . . → Read More: Gilead Acquires Cancer Therapy Biotech for $21B Comments are closed Finance biomedical, biotechnology, cancer, equity, investment, life sciences, merger, pharmaceuticals 
University of Oxford claims the top spot, followed by Stanford, Harvard, Cal Tech, MIT, Cambridge, University of California in Berkeley, and Yale. . . . → Read More: Infographic – U.S., U.K. Top University Rankings 
National Institutes of Health is starting two clinical trials testing a number of blood thinning treatments for people with blood clots from Covid-19 infections. . . . → Read More: NIH Trials Testing Covid-19 Blood Clot Therapies Comments are closed Joint ventures/collaborations, New products biomedical, clinical trials, Covid-19, life sciences, NIH, pharmaceuticals, university 
A new enterprise formed to discover human therapeutic antibodies is partnering with a synthetic biology company to discover Covid-19 antibody treatments. . . . → Read More: Antibody Discovery Company Forms, Partners on Covid-19 Comments are closed Finance, Joint ventures/collaborations biomedical, biotechnology, cancer, Covid-19, engineering, entrepreneurs, equity, investment, life sciences, mathematics, pharmaceuticals, physical sciences, venture capital |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts